---
figid: PMC11232665__ijmm-54-02-05395-g01
pmcid: PMC11232665
image_filename: PMC11232665__ijmm-54-02-05395-g01.jpg
figure_link: /pmc/articles/PMC11232665/figure/F2/
number: Figure 2
figure_title: Role of metformin.
caption: Role of metformin. In AS, metformin activates the AMPK pathway and inhibits
  IRS-1/2 phosphorylation and PI3K/Akt/mTOR signalling; in OA, metformin enhances
  the SIRT3/PINK1/Parkin, SIRT1 and ATF3 signalling pathways. Figure adapted from
  Server Medical Art (https://smart.servier.com/). AS, ankylosing spondylitis; ATF,
  activating transcription factor; IRS, insulin receptor substrate; OA, osteoarthritis;
  PI3K, phosphoinositide 3-kinases; PINK, PTEN-induced kinase; SIRT, sirtuin; Tmax,
  Peak Time; Cmax, Peak Concentration; T1/2, Elimination half-life
article_title: 'Metformin prevents the onset and progression of intervertebral disc
  degeneration: New insights and potential mechanisms (Review)'
citation: Wenzhi Yang, et al. Int J Mol Med. 2024 Aug;54(2).
year: '2024'
pub_date: 2024-8-
epub_date: 2024-7-02
doi: 10.3892/ijmm.2024.5395
journal_title: International Journal of Molecular Medicine
journa_nlm_ta: Int J Mol Med
publisher_name: D.A. Spandidos
keywords:
- metformin
- type 2 diabetes mellitus
- intervertebral disc degeneration
- nucleus pulposus
- mechanism
- treatment
---
